Medication & Treatment

Home >> partners >> Murli krishna Pharma

With a mission to build a best-in-class global digital infrastructure, Signzy revolutionizes the way organizations digitally onboard their customers and businesses.

Our product range covers a wide variety of therapeutic areas including PPIs, CNS, Anti-Infective, Immunosuppressant, Anti-Obesity, Alpha Blockers, Antiemetic, Anti-Fungal, Ophthalmology, Inhalation, Transdermal Liposomal Encapsulated Vitamins + Iron, and Oncology.

We are currently in the process of building two separate manufacturing units for sterile/transdermal formulations and oncology products, which will be ready in eight months. In the meantime, we are developing these products in our facility and providing contract-manufacturing services in an EU GMP facility.


With the coordination of DIISHA, MKPPL will ensure that the availability of drugs, supplements, and any consumable products are made available digitally to doctors and at the PHC window both. The most innovative and progressive segment upgrading STG (Standard treatment guidelines) and care. The quality parameters will ensure the optimum quantity of Vitamins like B12, D, Folic acid, and Iron. The increase in blood cells will be by one unit after usage of the prescribed dosage of 250 ml of the drug twice a day for 45 days.

MKPPL can produce one lakh bottles /month and double its capacity through minimal modifications and upgradation on or before December 2023. The plant can be upgraded to a higher capacity within a span of further three to four months to meet the target, which DIISHA has set of administering the Hematinic to over 25 million women spanning between 2024-2025.


Scroll to Top